HOLX · As filed with the SEC
Hologic balance sheet, by fiscal year
The statement as Hologic presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Consolidated Balance Sheets · USD
| USD | FY2025 Sep 27, 2025 | FY2024 Sep 28, 2024 | FY2023 Sep 30, 2023 | FY2022 Sep 24, 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| Current assets: | ||||
| Cash and cash equivalents | 1,959,500,000 | 2,160,200,000 | 2,722,500,000 | 2,339,500,000 |
| Short-term investments | 243,200,000 | 173,400,000 | — | — |
| Accounts receivable, less reserves | 600,800,000 | 600,400,000 | 625,600,000 | 617,600,000 |
| Inventory | 679,400,000 | 679,800,000 | 617,600,000 | 623,700,000 |
| Prepaid expenses and other current assets | 152,000,000 | 156,200,000 | 175,300,000 | 232,200,000 |
| Prepaid income taxes | 33,200,000 | 53,300,000 | 31,600,000 | 49,000,000 |
| Assets held-for-sale - current assets | — | 0 | 11,900,000 | — |
| Total current assets | 3,668,100,000 | 3,823,300,000 | 4,184,500,000 | 3,862,000,000 |
| Property, plant and equipment, net | 559,600,000 | 537,800,000 | 517,000,000 | 481,600,000 |
| Intangible assets, net | 589,100,000 | 844,600,000 | 888,600,000 | 1,280,600,000 |
| Goodwill | 3,640,600,000 | 3,443,100,000 | 3,281,300,000 | 3,236,500,000 |
| Long-term investments | 0 | 96,400,000 | — | — |
| Other assets | 557,500,000 | 410,800,000 | 267,900,000 | 210,500,000 |
| Total assets | 9,014,900,000 | 9,156,000,000 | 9,139,300,000 | 9,071,200,000 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||
| Current liabilities: | ||||
| Current portion of long-term debt | 2,900,000 | 37,500,000 | 287,000,000 | 15,000,000 |
| Accounts payable | 193,400,000 | 203,800,000 | 175,200,000 | 197,700,000 |
| Accrued expenses | 577,700,000 | 579,700,000 | 534,600,000 | 535,300,000 |
| Deferred revenue | 199,700,000 | 212,900,000 | 199,200,000 | 186,500,000 |
| Finance lease liabilities (current) | 3,500,000 | 3,300,000 | 3,100,000 | 3,200,000 |
| Assets held-for-sale - current liabilities | — | 0 | 8,200,000 | — |
| Total current liabilities | 977,200,000 | 1,037,200,000 | 1,207,300,000 | 937,700,000 |
| Long-term debt, net of current portion | 2,505,000,000 | 2,497,100,000 | 2,531,200,000 | 2,808,400,000 |
| Finance lease liabilities (non-current) | 9,000,000 | 12,200,000 | 15,300,000 | 18,000,000 |
| Deferred income tax liabilities | 43,400,000 | 59,400,000 | 20,200,000 | 90,800,000 |
| Deferred revenue, net of current portion | 12,400,000 | 13,800,000 | 13,800,000 | 9,400,000 |
| Other long-term liabilities | 420,000,000 | 406,300,000 | 334,600,000 | 330,700,000 |
| Stockholders’ equity: | ||||
| Preferred stock, $0.01 par value – 1,623 shares authorized; 0 shares issued | 0 | 0 | 0 | 0 |
| Common stock, $0.01 par value – 750,000 shares authorized; 302,438 and 301,185 shares issued, respectively | 3,000,000 | 3,000,000 | 3,000,000 | 3,000,000 |
| Additional paid-in-capital | 6,345,400,000 | 6,244,200,000 | 6,141,200,000 | 6,042,600,000 |
| Retained earnings | 3,411,500,000 | 2,845,800,000 | 2,056,300,000 | 1,600,300,000 |
| Treasury stock, at cost – 79,874 and 69,460 shares, respectively | (4,611,200,000) | (3,851,500,000) | (3,036,000,000) | (2,531,500,000) |
| Accumulated other comprehensive loss | (100,800,000) | (111,500,000) | (147,600,000) | (238,200,000) |
| Total stockholders’ equity | 5,047,900,000 | 5,130,000,000 | 5,016,900,000 | 4,876,200,000 |
| Total liabilities and stockholders’ equity | 9,014,900,000 | 9,156,000,000 | 9,139,300,000 | 9,071,200,000 |
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.